Evidence map›Paper›PMID 28090348›Full record

ArticleObesity science & practice2016

Changes in HbA

E Stener-Victorin, M Maliqueo, M Soligo, V Protto, L Manni, E Jerlhag, M Kokosar, A Sazonova, C J Behre, M Lind and 3 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Obesity science & practice, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
5.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 32 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Changes in HbAObesity science & practice · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 4 countries.

E Stener-VictorinDepartment of Physiology and Pharmacology Karolinska Institutet Stockholm Sweden.
M MaliqueoDepartment of Physiology and Pharmacology Karolinska Institutet Stockholm Sweden; Endocrinology and Metabolism Laboratory, West Division, School of Medicine University of Chile Santiago Chile.
M SoligoInstitute of Translational Pharmacology - CNR, via del Fosso del Cavaliere 100 Rome Italy.
V ProttoInstitute of Translational Pharmacology - CNR, via del Fosso del Cavaliere 100 Rome Italy.
L ManniInstitute of Translational Pharmacology - CNR, via del Fosso del Cavaliere 100 Rome Italy.
E JerlhagInstitute of Neuroscience and Physiology, Department of Pharmacology, Sahlgrenska Academy University of Gothenburg Gothenburg Sweden.
M KokosarInstitute of Neuroscience and Physiology, Department of Physiology, Sahlgrenska Academy University of Gothenburg Gothenburg Sweden.
A SazonovaDepartment of Obstetrics and Gynecology, Sahlgrenska Academy University of Gothenburg Sweden.
C J BehreInstitute of Neuroscience and Physiology, Department of Physiology, Sahlgrenska Academy University of Gothenburg Gothenburg Sweden.
M LindDepartment of Molecular and Clinical Medicine, Institute of Medicine University of Gothenburg Gothenburg Sweden.
C OhlssonCentre for Bone and Arthritis Research, Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy University of Gothenburg Gothenburg Sweden.
K HøjlundDepartment of Endocrinology Odense University Hospital Odense Denmark.
A BenrickInstitute of Neuroscience and Physiology, Department of Physiology, Sahlgrenska Academy University of Gothenburg Gothenburg Sweden; School of Health and Education University of Skövde Sweden.
University of Gothenburg · SEIstituto di Farmacologia Traslazionale · ITKarolinska Institutet · SEOdense University Hospital · DKSahlgrenska University Hospital · SEUniversity of Chile · CLUniversity of Skövde · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimInsulin sensitivity is ~40% lower in women with polycystic ovary syndrome (PCOS) than in controls. We tested the hypothesis that 5 weeks of electroacupuncture treatment improves glucose regulation and androgen levels in overweight/obese women with PCOS. MATERIAL AND

methodsSeventeen women with PCOS, aged 18 to 38 years, with a body mass index (BMI) ≥25 kg/m

resultsNo significant change in glucose homeostasis was observed, but HbA

conclusionFive weeks of electroacupuncture treatment improves HbA

Indexed as

Acupunctureadipose tissuehyperandrogenisminsulin resistancesympathetic nervous system

Identifiers

PMID28090348
PMCPMC5192539
OpenAlexW2529101015

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.